Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × Methods × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Colorectal Neoplasms 4 Neoplasms 3 Head and Neck Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Multiple Myeloma 1 Mucositis 1 Motor Activity 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lymphedema 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Diabetes Mellitus 1 Coronary Disease 1 Chronic Disease 1 Breast, Cervical or Colorectal Cancer Screening Needed 1 Bone Neoplasms 1 Body Weight Changes 1 Abnormalities, Radiation-Induced 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡